Hypertrophic reprogramming of the left ventricle: translation to the ECG

Joseph A Hill1

  • 1Department of Internal Medicine, Cardiology, University of Texas Southwestern Medical Center, Dallas, TX 75390-8573, USA. joseph.hill@utsouthwestern.edu

Journal of Electrocardiology
|September 25, 2012
PubMed

Insights

Left ventricular hypertrophy (LVH) is a common heart condition that increases heart failure risk. This overview explores the complex biology of LVH and its electrocardiography (ECG) manifestations.

Area of Science:

  • Cardiology
  • Physiology

Background:

  • Left ventricular hypertrophy (LVH) is a significant risk factor for adverse cardiac events, including heart failure.
  • Diagnosis of LVH often involves electrocardiography (ECG) and echocardiography, which can yield discordant results due to differing signal origins.

Purpose of the Study:

  • To provide an overview of the complex biology of left ventricular hypertrophy.
  • To enhance understanding of the electrocardiographic manifestations of LVH.

Main Methods:

  • Review of existing literature on LVH biology and diagnostic methods.
  • Analysis of the divergent signals used by ECG and echocardiography.

Main Results:

  • Echocardiography effectively measures ventricular mass, a key feature of LVH.
  • LVH involves diverse remodeling beyond mere muscle mass increase.
  • ECG changes reflect the electrophysiological alterations in hypertrophic hearts.

Conclusions:

  • Understanding the electrophysiological basis of ECG changes is crucial for interpreting LVH.
  • Integrating information from both ECG and echocardiography may improve LVH assessment.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
685
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
381
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
382